Latest News and Press Releases
Want to stay updated on the latest news?
-
Zutphen, The Netherlands - 10 March 2017 Esperite N.V. (Euronext: ESP, "Esperite") announces that it has convened an Extraordinary General Meeting of Shareholders ("EGM") to be held on Friday 21...
-
Not for distribution in the United States of America, Canada, Australia and Japan Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of...
-
Not for distribution in the United States of America, Canada, Australia and Japan Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of...
-
Zutphen, The Netherlands - 28 February 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") confirms that preparations for a significant external funding are still ongoing and Esperite...
-
Zutphen, The Netherlands - 31 December 2016 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announced during the year 2016 that it prepares a significant external funding to which the...
-
ESPERITE N.V.: Stem Cells, Genetic Tests and Pharmaceuticals Patent granted to Cell Factory in Europe confirms...
-
Esperite N.V. (ESP) expands extracellular vesicles (exosomes) products portfolio to include inflammatory bowel disease. The Cell Factory develops therapy for Crohn's disease. Esperite's business...
-
Esperite (ESP) leads international consortium for clinical translation of extracellular vesicles use in various therapies Extracellular vesicles...
-
ESPERITE N.V. (ESP) announces additional information on envisaged financing Zutphen, The Netherlands - 29 August 2016...
-
ESPERITE N.V. (ESP) publishes revenue increase of 6% compared to HY1 2015 and 8% compared to HY2 2015 Significant...